Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Kronos Bio, Inc. | 3,368,283 | reported | 14 Oct 2020 | tx 7+3,798,832−2,827,047 |
| X4 Pharmaceuticals, Inc | 10,000 | reported | 05 Jun 2018 | tx 10+909,963−1,589,024 |
1 purchase reported after at least 12 months of silence — most recent on 14 Oct 2020.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 Oct 2020 | CONVERSION | Kronos Bio, Inc. | 1,606,220 | — | |
| 14 Oct 2020 | PURCHASE | Kronos Bio, Inc. | 450,000 | 19.00 USD | first after silence |
| 14 Oct 2020 | CONVERSION | Kronos Bio, Inc. | 366,299 | 16.15 USD | |
| 14 Oct 2020 | CONVERSION | Kronos Bio, Inc. | 1,376,313 | — | |
| 14 Oct 2020 | CONVERSION | Kronos Bio, Inc. | 1,522,484 | — | deriv |
| 14 Oct 2020 | CONVERSION | Kronos Bio, Inc. | 1,304,563 | — | deriv |
| 14 Oct 2020 | CONVERSION | Kronos Bio, Inc. | — | 0.00 USD | deriv |
| 05 Jun 2018 | GRANT_AWARD | X4 Pharmaceuticals, Inc | 10,000 | 0.00 USD | deriv |
| 15 Nov 2017 | GRANT_AWARD | X4 Pharmaceuticals, Inc | 7,324 | 0.00 USD | deriv |
| 20 Nov 2017 | PURCHASE | X4 Pharmaceuticals, Inc | 300,000 | 10.00 USD | |
| 20 Nov 2017 | CONVERSION | X4 Pharmaceuticals, Inc | 279,079 | — | |
| 20 Nov 2017 | CONVERSION | X4 Pharmaceuticals, Inc | 246,682 | — | |
| 20 Nov 2017 | CONVERSION | X4 Pharmaceuticals, Inc | 41,878 | — | |
| 20 Nov 2017 | CONVERSION | X4 Pharmaceuticals, Inc | 84,040 | 0.00 USD | deriv |
| 20 Nov 2017 | CONVERSION | X4 Pharmaceuticals, Inc | 952,497 | 0.00 USD | deriv |
| 20 Nov 2017 | CONVERSION | X4 Pharmaceuticals, Inc | 552,487 | 0.00 USD | deriv |